Evidence map›Paper›PMID 23824248›Full record

ArticleJournal of psychopharmacology (Oxford, England)2013

Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala.

Bettina Hornboll, Julian Macoveanu, James Rowe, Rebecca Elliott, Olaf B Paulson, Hartwig R Siebner, Gitte M Knudsen

Abstract readControlled Clinical Trial
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Fluctuations in [¹¹C]SB207145 PET binding associated with change in threat-related amygdala reactivity in humans.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Trial
  6. Article
  7. Article
  8. Article
  9. Anxiety and depression: A top-down, bottom-up model of circuit function.Annals of the New York Academy of Sciences · 2023
    Review
  10. Elevated levels of serotonin 5-HTEuropean archives of psychiatry and clinical neuroscience · 2023
    Article
  11. Article
  12. Article
  13. Functional Characterization of 5-HTThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  14. Article
  15. Article
  16. Targeting Serotonin 5-HTAggression and violent behavior
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Bettina Hornboll1Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Julian Macoveanu
James Rowe
Rebecca Elliott
Olaf B Paulson
Hartwig R Siebner
Gitte M Knudsen
Hvidovre Hospital · DKCopenhagen University Hospital · DKUniversity of Cambridge · GBUniversity of Manchester · GB

Funding

Medical Research Council MC_U105597119Wellcome Trust 088324
6 · The paper itself

Abstract

backgroundThe serotonin 2A (5-HT2A) receptor has been implicated in neural-processing of emotionally salient information. To elucidate its role in processing of fear and anger, healthy individuals were studied with functional magnetic resonance imaging (fMRI) after 5-HT2A receptor blockade, while judging the gender of neutral, fearful and angry faces.

methods5-HT2A receptors were blocked with ketanserin to a variable degree across subjects by adjusting the time between ketanserin-infusion and onset of the fMRI protocol. Neocortical 5-HT2A receptor binding in terms of the binding potential (BPp ) was assessed prior to fMRI with (18)F-altanserin positron emission tomography (PET) and subsequently integrated in the fMRI data analysis. Also functional connectivity analysis was employed to evaluate the effect of ketanserin blocking on connectivity.

resultsCompared to a control session, 5-HT2A receptor blockade reduced the neural response to fearful faces in the medial orbitofrontal cortex (OFC), independently of 5-HT2A receptor occupancy or neocortical 5-HT2A receptor BPp . The medial OFC also showed increased functional coupling with the left amygdala during processing of fearful faces depending on the amount of blocked 5-HT2A receptors.

conclusions5-HT2A receptor mediated signaling increases the sensitivity of the OFC to fearful facial expressions and regulates the strength of a negative feedback signal from the OFC to amygdala during processing of fearful faces.

Indexed as

Facial ExpressionFearAdultAmygdalaAngerCitalopramFemaleFrontal LobeFunctional NeuroimagingHealthy VolunteersHumansKetanserinMagnetic Resonance ImagingMaleNeural PathwaysPhotic StimulationCitalopramKetanserinReceptor, Serotonin, 5-HT2ASelective Serotonin Reuptake InhibitorsSerotonin 5-HT2 Receptor AntagonistsTryptophanemotionfearful facesFunctional magnetic resonance imagingketanserinpositron emission tomographyserotoninserotonin 2A receptors

Identifiers

PMID23824248
PMCPMC4606977
OpenAlexW2118492070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.